BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34181087)

  • 1. A clinicoradiological analysis of silent corticotroph adenomas after the introduction of pituitary-specific transcription factors.
    Goyal-Honavar A; Sarkar S; Asha HS; Kapoor N; Balakrishnan R; Vanjare H; Chacko G; Chacko AG
    Acta Neurochir (Wien); 2021 Nov; 163(11):3143-3154. PubMed ID: 34181087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review.
    Langlois F; Lim DST; Yedinak CG; Cetas I; McCartney S; Cetas J; Dogan A; Fleseriu M
    Pituitary; 2018 Feb; 21(1):32-40. PubMed ID: 29032459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Parameters of Silent Corticotroph Adenomas With Positive and Negative Adrenocorticotropic Hormone Immunostaining: A Large Retrospective Single-Center Study of 105 Cases.
    Zhang K; Shou X; Chen H; Qiao N; He W; Chen Z; Shen M; Li S; Zhao Y; Zhang Z; Li Y; Ye H; Wang Y
    Front Endocrinol (Lausanne); 2020; 11():608691. PubMed ID: 33584540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical profiles of silent corticotroph adenomas compared with silent gonadotroph adenomas after adopting the 2017 WHO pituitary classification system.
    Jiang S; Zhu J; Feng M; Yao Y; Deng K; Xing B; Lian W; Wang R; Bao X
    Pituitary; 2021 Aug; 24(4):564-573. PubMed ID: 33651318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silent corticotroph pituitary adenomas: clinical characteristics, long-term outcomes, and management of disease recurrence.
    Strickland BA; Shahrestani S; Briggs RG; Jackanich A; Tavakol S; Hurth K; Shiroishi MS; Liu CJ; Carmichael JD; Weiss M; Zada G
    J Neurosurg; 2021 May; 135(6):1706-1713. PubMed ID: 33962375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic versus non-cystic silent corticotrophic adenomas: clinical and histological analysis of 62 cases after microscopic transsphenoidal surgery-a retrospective, single-center study.
    Sumislawski P; Huckhagel T; Krajewski KL; Aberle J; Saeger W; Flitsch J; Rotermund R
    Sci Rep; 2023 Feb; 13(1):2468. PubMed ID: 36774403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silent corticotroph adenomas: Emory University cohort and comparison with ACTH-negative nonfunctioning pituitary adenomas.
    Ioachimescu AG; Eiland L; Chhabra VS; Mastrogianakis GM; Schniederjan MJ; Brat D; Pileggi AV; Oyesiku NM
    Neurosurgery; 2012 Aug; 71(2):296-303; discussion 304. PubMed ID: 22517250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive long-term retrospective analysis of silent corticotrophic adenomas vs hormone-negative adenomas.
    Jahangiri A; Wagner JR; Pekmezci M; Hiniker A; Chang EF; Kunwar S; Blevins L; Aghi MK
    Neurosurgery; 2013 Jul; 73(1):8-17; discussion 17-8. PubMed ID: 23685641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silent corticogonadotroph adenomas: clinical and cellular characteristics and long-term outcomes.
    Cooper O; Ben-Shlomo A; Bonert V; Bannykh S; Mirocha J; Melmed S
    Horm Cancer; 2010 Apr; 1(2):80-92. PubMed ID: 20717480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, Laboratory, and Treatment Profiles of Silent Corticotroph Adenomas That Have Transformed to the Functional Type: A Case Series With a Literature Review.
    Zheng G; Lu L; Zhu H; You H; Feng M; Liu X; Dai C; Yao Y; Wang R; Zhang H; Sun X; Lu Z
    Front Endocrinol (Lausanne); 2020; 11():558593. PubMed ID: 33071973
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical Parameters to Distinguish Silent Corticotroph Adenomas from Other Nonfunctioning Pituitary Adenomas.
    Kim D; Ku CR; Park SH; Moon JH; Kim EH; Kim SH; Lee EJ
    World Neurosurg; 2018 Jul; 115():e464-e471. PubMed ID: 29678704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning pituitary adenomas.
    Cho HY; Cho SW; Kim SW; Shin CS; Park KS; Kim SY
    Clin Endocrinol (Oxf); 2010 May; 72(5):648-53. PubMed ID: 19650787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently.
    Bradley KJ; Wass JA; Turner HE
    Clin Endocrinol (Oxf); 2003 Jan; 58(1):59-64. PubMed ID: 12519413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of silent corticotroph pituitary neuroendocrine tumors (PitNETs) from non-functioning PitNETs using kinetic analysis of dynamic MRI.
    Amano T; Masumoto T; Watanabe D; Hoshiai S; Mori K; Sakamoto N; Kino H; Akutsu H; Nakajima T
    Jpn J Radiol; 2023 Sep; 41(9):938-946. PubMed ID: 37027094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiomics analysis allows for precise prediction of silent corticotroph adenoma among non-functioning pituitary adenomas.
    Rui W; Qiao N; Wu Y; Zhang Y; Aili A; Zhang Z; Ye H; Wang Y; Zhao Y; Yao Z
    Eur Radiol; 2022 Mar; 32(3):1570-1578. PubMed ID: 34837512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Relevance and Immunohistochemical Patterns of Silent Pituitary Adenomas: 10 Years of Single-centre Experience.
    Akkus G; Karagun B; Çetinalp NE; Açıkalın A; Evran M; Sengöz S; Sert M; Zorludemir S; Tetiker T
    Curr Med Imaging; 2021; 17(2):310-317. PubMed ID: 33357196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative hypothalamic pituitary adrenal function in patients with silent corticotroph adenomas.
    Cheres AF; ElAsmar N; Rajpal A; Selman WR; Arafah BM
    Pituitary; 2017 Aug; 20(4):471-476. PubMed ID: 28528397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Course and Unique Features of Silent Corticotroph Adenomas.
    Huang L; Fatterpekar G; Charles S; Golub D; Zagzag D; Agrawal N
    World Neurosurg; 2022 May; 161():e274-e281. PubMed ID: 35131523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing's disease.
    Raverot G; Wierinckx A; Jouanneau E; Auger C; Borson-Chazot F; Lachuer J; Pugeat M; Trouillas J
    Eur J Endocrinol; 2010 Jul; 163(1):35-43. PubMed ID: 20385723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features of silent corticotroph adenomas.
    Alahmadi H; Lee D; Wilson JR; Hayhurst C; Mete O; Gentili F; Asa SL; Zadeh G
    Acta Neurochir (Wien); 2012 Aug; 154(8):1493-8. PubMed ID: 22619024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.